iTeos Therapeutics (ITOS) Ownership - Who owns iTeos Therapeutics?

19 days until earnings call

Profile

Industry
N/A
Address
321 Arsenal Street
Phone
+1 339 217-0162
Employees
157
Web
https://www.iteostherapeutics.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
568.21M
P/E Ratio
N/A
Total Cash
449.14M
Projected Growth
N/A
Total Debt
5.82M
Revenue
N/A
Risk (Beta)
1.15
Dividend Yield
N/A
Total Cash/Share
12.43
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price

Fundamentals

ITOS
Capitalization
568M
P/E Ratio
N/A
Risk (Beta)
1.15
Dividend Yield
N/A
Total Cash
449M
Total Cash/Share
12.43
Total Debt
5.82M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
541M
P/B Ratio
1.05
Cash Flow
N/A
Earnings
-3.78
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
36K
Current Ratio
13.51
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-165.54M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-19.93
Shares Held By Institutions
1.7B
Shares Outstanding - Current
36.1M
Total Liabilities
88.6M
Total Volume MTD
N/A
Value
-1
Gain YTD
48.858
View a ticker or compare two or three
ITOS
Daily Signal changed days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a company, which engages in the development of biopharmaceuticals therapeutic products and services

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
321 Arsenal Street
Phone
+1 339 217-0162
Employees
157
Web
https://www.iteostherapeutics.com